Mar 9, 2021 05:00PM
Mar 4, 2021 08:31AM
Mar 4, 2021 08:30AM
Mar 4, 2021 08:30AM
Mar 2, 2021 04:05PM
Jan 15, 2021 06:58AM
Jan 15, 2021 06:55AM Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab Plus Chemotherapy as a Frontline Targeted Treatment for FGFR2b+ G
Dec 9, 2020 05:00PM
Nov 11, 2020 05:45PM
Nov 11, 2020 05:45PM
Nov 10, 2020 04:14PM
Nov 10, 2020 04:12PM
Nov 3, 2020 04:10PM
Nov 3, 2020 04:05PM Five Prime Therapeutics Reports Third Quarter 2020 Results
Nov 2, 2020 06:30PM
Oct 27, 2020 10:29PM
Aug 6, 2020 04:05PM
Jul 29, 2020 06:30PM
May 7, 2020 04:05PM
Apr 30, 2020 04:05PM
Feb 27, 2020 04:50PM Five Prime Therapeutics (FPRX) Tops Q4 EPS by 7c
Feb 27, 2020 04:05PM
Feb 13, 2020 04:05PM
Nov 6, 2019 05:29PM
Nov 6, 2019 04:05PM
Oct 24, 2019 04:01PM
Aug 7, 2019 04:05PM
Jul 31, 2019 09:16PM Five Prime Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call
May 8, 2019 04:58PM
May 8, 2019 04:05PM
Apr 17, 2019 07:56PM
Feb 26, 2019 04:38PM
Feb 26, 2019 04:05PM
Feb 7, 2019 04:05PM
Nov 9, 2018 08:40AM New Research Coverage Highlights American Public Education, Protagonist Therapeutics, TravelCenters of America, Five Prime Therapeutics, Red Robin Gourmet Burgers, and Hemisphere Media Group — Conso
Nov 6, 2018 04:57PM
Nov 6, 2018 04:05PM
Oct 23, 2018 04:05PM
Aug 8, 2018 04:47PM
Aug 8, 2018 04:05PM
Jul 26, 2018 04:05PM
May 8, 2018 04:29PM Five Prime Therapeutics (FPRX) Misses Q1 EPS by 8c
May 8, 2018 04:05PM
Apr 24, 2018 04:05PM
Feb 27, 2018 04:27PM
Feb 27, 2018 04:05PM
Feb 13, 2018 04:05PM
Nov 30, 2017 08:30AM
Nov 6, 2017 04:37PM Five Prime Therapeutics (FPRX) Misses Q3 EPS by 30c
Nov 6, 2017 04:05PM

1,198,655 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All